NASDAQ · Analyst Forecast

SELLAS Life Sciences Group, Inc. (SLS) Stock Forecast & Price Target

$19.15 NASDAQ: SLS Market Cap $3.90B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering SELLAS Life Sciences Group, Inc. (SLS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For SELLAS Life Sciences Group, Inc., analysts forecast revenue rising from $31.98M in 2025 to $630.29M in 2030; the average estimate for 2030 earnings per share is $2.34; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$19.15
Consensus targetThe average of the price targets analysts have published.$35.00
Median targetThe middle target, less affected by a single outlier.$35.00
Highest targetThe most optimistic published target.$35.00
Lowest targetThe most pessimistic published target.$35.00
Difference from priceHow far the consensus target sits from today’s price.+82.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$31.98M$31.98M$31.98M2
2026$36.13M$36.13M$36.13M1
2027$53.09M$53.09M$53.09M2
2028$122.04M$122.04M$122.04M2
2029$357.59M$357.59M$357.59M1
2030$630.29M$630.29M$630.29M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.26−$0.26−$0.262
2026−$0.20−$0.20−$0.201
2027−$0.20−$0.10$0.012
2028−$0.20$0.04$0.272
2029$1.23$1.23$1.231
2030$2.34$2.34$2.341

SELLAS Life Sciences Group, Inc. (SLS) forecast — frequently asked questions

What is the analyst price target for SELLAS Life Sciences Group, Inc.?

Analysts covering SELLAS Life Sciences Group, Inc. (SLS) have a consensus price target of $35.00, 82.8% above the current price of $19.15. Published targets range from $35.00 to $35.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for SELLAS Life Sciences Group, Inc.'s earnings?

The average analyst estimate for SELLAS Life Sciences Group, Inc. (SLS) earnings per share in 2030 is 2.34, with individual estimates between 2.34 and 2.34.

How much revenue is SELLAS Life Sciences Group, Inc. expected to make?

Analysts forecast SELLAS Life Sciences Group, Inc. (SLS) revenue of $630.29M in 2030, based on 1 published estimates.

How many analysts cover SLS?

2 analysts contribute estimates for SELLAS Life Sciences Group, Inc. (SLS). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.